ThioLogics, a UCL Business company, spun-out of the UCL Department of Chemistry has entered into a new collaboration with Novozymes Biopharma.

Study shows little progress in bridging the gap between the world’s networked economies and rest of world; Nordic countries dominate Networked Readiness Index, while emerging markets struggle most in realising digital potential

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases.

ATTRACT brings science development to open innovation in products and services in industry, education, research and policy. The project is currently seeking potential partners.

With just a week to go until this year's Imperial Festival, final preparations are underway to launch the UK's largest robotics network at the event.

The James Dyson Foundation has donated £8m to create a technology hub at the heart of Cambridge, providing the University of Cambridge’s brightest engineers with some of the world’s most advanced engineering laboratories.

Some of the UK's most promising entrepreneurs will have access to an innovative new business education programme launched at Imperial today.

Director of UCL Advances and Director of UCL Enterprise Operations, Timothy Barnes, has won the Queen’s Award for Enterprise Promotion.

In the framework of the EU-project Solarjet, scientists demonstrate for the first time the entire production path to liquid hydrocarbon fuels from water, CO2 and solar energy. The key technological component is a solar reactor developed at ETH Zurich.

The structure of sodium channels – which play an essential role in the functioning of heart and nerve cells – are different than previously believed. Researchers hope their discovery will lead to improvements in drugs that act on the sodium channel to treat a range of cardiac and pain conditions.